Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Isolation of fusion-competent myoblasts and therapeutic applications thereof related to muscular dystrophy

Isolation of fusion-competent myoblasts and therapeutic applications thereof related to muscular dystrophy

US Patent 11318167 · Granted May 3, 2022

Estimated economic value: $49,173,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Electronic device for providing augmented reality service, and operating method 2025
Optically controllable FGFR stimulation using wireless controlled cellular light2025
Optically controllable FGFR stimulation using wireless controlled cellular light2025
Optically controllable FGFR stimulation using wireless controlled cellular light2025
Human iPSC-based drug testing platform for muscular dystrophy2024
Human iPSC-based drug testing platform for muscular dystrophy2024
Electronic device displaying widget and method for controlling the same2024
Electronic device and method for controlling display of a plurality of objects o2024
AAV capsids identified by in vivo library selection2024
Electronic device for providing augmented reality service and operating method t2024
Electronic device for processing user input and method thereof2024
Method for wireless connection in augmented reality environment and electronic d2023